Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation

PURPOSE: TNM Stage 3B encompasses a wide range of primary tumor and nodal metastatic tumor burden. This study aimed to evaluate the prognostic value of quantitative FDG PET/CT parameters in patients with newly diagnosed Stage 3B Non-Small Cell Lung Cancer (NSCLC). MATERIALS AND METHODS: Institutiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Dashevsky, Brittany Z., Zhang, Chenpeng, Yan, Li, Yuan, Cindy, Xiong, Lingyun, Liu, Yongmei, Liu, Haiyan, Kong, Feng-Ming Spring, Pu, Yonglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954780/
https://www.ncbi.nlm.nih.gov/pubmed/29782599
http://dx.doi.org/10.1186/s41824-017-0013-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954780/
https://www.ncbi.nlm.nih.gov/pubmed/29782599
http://dx.doi.org/10.1186/s41824-017-0013-z

Ejemplares similares